Emisphere’s Eligen(R) Technology Demonstrates Delivery Of Active Recombinant Human Growth Hormone (Medical News Today)

Emisphere’s Eligen(R) Technology Demonstrates Delivery Of Active Recombinant Human Growth Hormone (Medical News Today)
Emisphere Technologies, Inc. (”Emisphere”) (Nasdaq: EMIS) announced today that Novartis Pharma AG has notified Emisphere of new Phase I data indicating that recombinant human growth hormone (rhGH) can be absorbed when given to growth hormone-deficient (GHD) patients in a prototype oral formulationusing Emisphere’s eligen(R) delivery technology. [click link for full article]

TECHNOLOGY BRIEFING - Washington Post

TECHNOLOGY BRIEFING - Washington Post
Earthtimes.orgTECHNOLOGY BRIEFINGWashington Post, United States - 33 minutes ago… Comverse Technology, which is preparing to restate earnings after it found that stock options were manipulated, requested another deadline extension from the … HP Director May Lose Seat to News Leaks New York TimesPerkins Goes Up Against HP?Again BusinessWeekHP Director May Lose Seat to News Leaks New York TimesReuters - CNET News.comall 65 news articles

Reksoft Brings Technology Innovation to the Postal Service Business

Reksoft Brings Technology Innovation to the Postal Service Business
Reksoft, the software outsourcing vendor with primary resource base in St. Petersburg, Russia announced that it successfully developed an innovative software solution to raise the efficiency of Germany?s leading manufacturer of franking machines, Francotyp-Postalia. (PRWEB Sep 6, 2006)